Cognism vs. ZoomInfo: How to Build a Targeted Pharmaceutical Sales Prospect List

Choose Cognism if your pharmaceutical sales team needs cleaner compliant contact data in Europe, and choose ZoomInfo if you need a larger U.S.-heavy database with strong company signals and workflow depth. For pharma prospecting, the real win is not “more contacts.” It is building a list of the right medical affairs leaders, procurement buyers, lab directors, biotech founders, and commercial decision-makers before your competitors reach them. The FDA’s Center for Drug Evaluation and Research approved 55 novel drugs in 2023, showing how active the market remains for suppliers, data vendors, CROs, CDMOs, lab tech, packaging firms, and specialty service providers [source: FDA].

TLDR: Cognism is usually better for pharmaceutical prospecting when privacy, direct dials, and European coverage matter. ZoomInfo is often stronger when you want broad U.S. account discovery, firmographic filters, intent data, and sales engagement add-ons. For example, a CRO selling trial recruitment services could build a list of 500 oncology biotech accounts, cut it to 120 active-fit prospects, then assign 40 high-priority leads to sales based on funding, hiring, and drug pipeline signals. If your total addressable market is global, many teams test both tools on the same 100 target accounts before committing.

Why pharmaceutical prospect lists are harder than ordinary B2B lists

Pharmaceutical sales prospecting is messy. Job titles vary wildly. A “Head of External Innovation” may buy from you. So may a “Director of Strategic Sourcing,” “VP Clinical Operations,” or “Lab Manager.” One company can have research sites, manufacturing sites, commercial offices, and holding entities. Honestly, it feels like some databases treat all of those as the same target. That is how reps end up calling the wrong office.

A useful pharma prospect list needs five things:

• Accurate company segmentation: biotech, pharma, CDMO, CRO, diagnostics, medical device, API supplier, specialty distributor.
• Contact precision: direct dials, verified emails, seniority, role, department, and location.
• Compliance comfort: especially for GDPR, PECR, and consent-based outreach.
• Buying signals: funding, product launches, clinical trials, hiring, facility expansion, or new approvals.
• CRM hygiene: clean exports, duplicate control, and fields your sales team will actually use.

Cognism vs. ZoomInfo at a glance

Cognism is known for compliant B2B contact data, strong European coverage, and phone-verified contact access through its Diamond Data offering. It is a good fit for pharma teams selling into the UK, EU, and global life sciences accounts where privacy risk is a real concern.

ZoomInfo is known for database scale, broad U.S. company coverage, OrgCharts, intent signals, and a wide set of go-to-market tools. It suits teams that want prospecting, enrichment, engagement, and account intelligence in one system.

The catch is that neither tool “understands pharma” perfectly out of the box. You still need a tight account definition. If you search only for “pharmaceutical companies,” you will miss biotechs, trial sites, therapeutic startups, and CDMOs that are just as likely to buy.

Step 1: Define the pharmaceutical buyer you want

Start with a narrow ideal customer profile. Do not begin with job titles. Begin with the buying situation.

Ask these questions:

• Are you selling to R&D, clinical operations, manufacturing, procurement, compliance, or commercial teams?
• Do you need companies with active drug trials?
• Are you targeting preclinical biotech, mid-market pharma, or enterprise drug manufacturers?
• Which regions matter? U.S., UK, DACH, Nordics, France, Switzerland, India, or global?
• Do you need headquarters contacts or site-specific contacts?

For example, a vendor selling cold-chain packaging should not target every pharma company. Better filters would be: companies with biologics products, late-stage trials, manufacturing facilities, quality leaders, and supply chain directors. That list will be smaller. It will also be far more usable.

Step 2: Build the list in Cognism

In Cognism, start with company filters. Use industry, headcount, country, revenue band, and keywords such as biotechnology, clinical research, pharmaceutical manufacturing, drug development, or oncology.

Then filter contacts by department and seniority. For pharma, strong title clusters include:

• Clinical: VP Clinical Operations, Clinical Trial Manager, Head of Clinical Development.
• Scientific: Chief Scientific Officer, Director of Research, Head of Translational Medicine.
• Manufacturing: Director of Manufacturing, Head of Quality, GMP Operations Manager.
• Commercial: Market Access Director, Brand Lead, VP Commercial Strategy.
• Procurement: Strategic Sourcing Manager, Procurement Director, Supplier Manager.

Cognism is especially useful when phone outreach is part of your process. Direct dials can save reps hours. That matters when senior pharma contacts rarely answer generic switchboard calls. It drives me crazy when a rep spends 15 minutes chasing one bad main number, then logs “no answer” as if the account was dead.

Step 3: Build the list in ZoomInfo

ZoomInfo shines when your account research depends on signals. Use its company database to surface pharma and biotech accounts by size, region, funding, technologies, hiring patterns, and intent topics. For U.S. prospecting, this can move fast.

Useful ZoomInfo filters for pharma sales include:

• Industry and subindustry: biotechnology, pharmaceuticals, life sciences, medical devices.
• Company growth: recent funding, employee growth, new locations.
• Intent topics: clinical trial management, GMP manufacturing, pharmacovigilance, lab automation.
• Technographics: CRM, ERP, lab systems, analytics tools, compliance software.
• Org structure: parent company, subsidiaries, department maps, reporting lines.

If you sell to large pharma accounts, ZoomInfo’s org and company data can help you find multiple entry points. That is useful because one buying committee may include procurement, IT, quality, legal, and a scientific sponsor.

Cognism strengths for pharma prospecting

• Compliance focus: helpful for teams contacting prospects in Europe.
• Strong phone data: useful for account executives who still use calling as a core channel.
• Simple targeting: easier for lean sales teams that need clean lists without too much setup.
• Global coverage: strong fit for teams that do not want to rely only on U.S. data.

Cognism is a smart pick for pharma suppliers selling into regulated regions. Think pharmacovigilance software, regulatory consulting, QA services, lab equipment, and CRO services with UK or EU targets.

ZoomInfo strengths for pharma prospecting

• Large database: strong for building broad account pools.
• Buying signals: useful when timing matters.
• Sales workflow features: prospecting, enrichment, routing, and engagement tools can sit together.
• Account mapping: helpful for enterprise pharma accounts with many departments.

ZoomInfo fits teams that want to create account tiers fast. For example, Tier 1 could include 75 large pharma companies with active hiring in clinical operations. Tier 2 could include 300 funded biotechs. Tier 3 could include 1,000 smaller life sciences firms for automated nurture.

How to clean and prioritize your final list

Do not export 5,000 contacts and call it strategy. That is just a spreadsheet headache. Use a scoring model before your team touches the data.

1. Fit score: industry, size, region, product area, facility type.
2. Need score: funding, trials, hiring, expansion, new product activity.
3. Access score: direct dial, verified email, LinkedIn profile, correct department.
4. Timing score: intent data, recent news, trigger event, budget cycle.

A simple 100-point score works well. Give 40 points to fit, 25 to need, 20 to access, and 15 to timing. Then split accounts into A, B, and C groups. Sales should call A accounts first. Marketing can warm up B accounts. C accounts can wait.

Which platform should you choose?

Pick Cognism if your team values compliant outreach, European data, and phone-ready contacts. Pick ZoomInfo if you need a bigger account universe, U.S. depth, intent signals, and detailed company intelligence.

The best answer may be a short bake-off. Take 100 pharmaceutical target accounts. Run the same search in both tools. Compare match rate, valid emails, direct dials, title accuracy, duplicate rate, and CRM field quality. If Cognism gives you 68 usable decision-makers and ZoomInfo gives you 91, ZoomInfo may win. If Cognism gives you fewer contacts but 30% more valid direct dials in your key region, Cognism may be the better sales tool.

The smartest pharmaceutical prospect list is not the biggest one. It is the one your reps trust enough to use. Build it around real buying triggers, clean contact data, and a clear account score. Cognism and ZoomInfo can both help. Your market, region, and outreach style should decide the winner.